Australia markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
289.54-3.26 (-1.11%)
At close: 04:00PM EDT
289.20 -0.34 (-0.12%)
After hours: 07:25PM EDT
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Assets
Current assets
Cash
Cash and cash equivalents
6,795,000
5,988,187
3,109,322
2,650,134
Other short-term investments
729,900
670,710
698,972
518,108
Total cash
7,524,900
6,658,897
3,808,294
3,168,242
Net receivables
1,136,800
885,352
633,518
409,688
Inventory
353,100
280,777
167,502
124,360
Other current assets
187,200
-
-
-
Total current assets
9,560,600
8,133,379
4,822,829
3,843,109
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,320,400
2,074,678
1,437,620
1,263,448
Accumulated depreciation
-896,000
-790,580
-692,540
-451,443
Net property, plant and equipment
1,424,400
1,284,098
745,080
812,005
Goodwill
1,002,200
1,002,158
1,002,158
50,384
Intangible assets
400,000
400,000
400,000
-
Other long-term assets
110,800
49,394
157,583
40,728
Total non-current assets
3,871,900
3,618,429
3,495,636
2,402,789
Total assets
13,432,500
11,751,808
8,318,465
6,245,898
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
195,000
155,139
87,610
110,987
Accrued liabilities
1,266,900
1,135,394
946,041
857,791
Deferred revenues
171,700
191,519
62,332
-
Other current liabilities
49,800
83,470
37,680
40,589
Total current liabilities
2,142,000
1,877,533
1,334,827
1,120,292
Non-current liabilities
Deferred tax liabilities
-
-
-
0
Deferred revenues
-
-
88,762
82,573
Other long-term liabilities
303,300
297,955
186,764
26,280
Total non-current liabilities
1,190,500
1,187,460
898,394
690,403
Total liabilities
3,332,500
3,064,993
2,233,221
1,810,695
Stockholders' equity
Common stock
2,500
2,599
2,589
2,546
Retained earnings
3,200,800
858,669
-1,852,978
-2,989,478
Accumulated other comprehensive income
15,900
-68,480
-1,973
659
Total stockholders' equity
10,100,000
8,686,815
6,085,244
4,435,203
Total liabilities and stockholders' equity
13,432,500
11,751,808
8,318,465
6,245,898